ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
66.789,38
-0,43%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. HCW Biologics Inc (HCWB)

  7. HCW Biologics Inc (HCWB) News

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HCWB
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202423h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
15/05/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
15/05/202422h39GlobeNewswire Inc.HCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
15/05/202422h35Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HCWBHCW Biologics Inc
01/04/202422h10GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsNASDAQ:HCWBHCW Biologics Inc
27/02/202422h27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
22/02/202420h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
22/02/202420h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
22/02/202420h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
22/02/202420h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
22/02/202414h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
12/01/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/12/202322h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
11/12/202322h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
20/11/202322h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
14/11/202313h00GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
08/11/202313h30GlobeNewswire Inc.Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNASDAQ:HCWBHCW Biologics Inc
01/11/202312h30GlobeNewswire Inc.Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingNASDAQ:HCWBHCW Biologics Inc
23/10/202322h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
18/09/202322h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
16/09/202300h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
13/09/202323h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
08/09/202323h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
07/09/202322h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
06/09/202313h30GlobeNewswire Inc.HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023NASDAQ:HCWBHCW Biologics Inc
31/08/202313h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
24/08/202313h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/08/202313h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
11/08/202313h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/08/202313h00GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HCWB

Kürzlich von Ihnen besucht

ASX
XJOWOG
CSE
NVRO
EnviroGold Global
COIN
SONGGBP
COIN
TIAKRW
Celestia
BIT
S29608
Societe Generale Effekten
USOTC
BPHLF
Bank of Philippine Islands (PK)
GATE
SLIMUSDT
Solanium
NASDAQ
FTVIW
FinTech Acquisition Corp...
TSX
TECX
TD Global Technology Lea...
NYSE
FATH
Fathom Digital Manufactu...
ASX
OLE
Olea Australis
LSE
0MN7
TSXV
NUG
Nulegacy Gold
BIT
GS0225
Goldman Sachs
EU
IQCT
Lyxor MSCI Smart Cities ...
ASX
FXZKOB
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten